Australia approves CSL's H1N1 vaccine
This article was originally published in Scrip
Executive Summary
Australia has approved the local biotech firm CSL's pandemic (H1N1) vaccine (Panvax) for use in people aged 10 years and over, making it the third country to OK a swine flu vaccine, following the US and China.